SCHEMBL23720099

SCHEMBL23720099

OCC#CCCCCc1cccc(CCCO)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.42
CYP4A11 Q02928 2/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TBXA2R P21731 1/20 0.40
NOS1 P29475 1/20 0.37
IGF1R P08069 1/20 0.36
ALOX15 P16050 1/20 0.36
LPL P06858 2/20 0.36
LIPG Q9Y5X9 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
LTA4H P09960 1/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL241880 0.81 CYP4F2 (0.53) CYP4F2CYP4A11MEN1KMT2ATBXA2R
SCHEMBL238401 0.79 CYP4F2 (0.58) CYP4F2CYP4A11MEN1KMT2ATBXA2R
SCHEMBL18917596 0.78 CYP4F2 (0.40) CYP4F2CYP4A11MEN1KMT2ATBXA2R
SCHEMBL2176833 0.77 CYP4F2 (0.56) CYP4F2CYP4A11TBXA2RNOS1IGF1R
SCHEMBL1244841 0.75 CYP4F2 (0.49) CYP4F2CYP4A11MEN1KMT2ATBXA2R
SCHEMBL28150919 0.73 LPL (0.62) CYP4F2CYP4A11LPLLIPGKDM4E
SCHEMBL80185 0.72 CYP4A11 (0.58) CYP4F2CYP4A11TBXA2RNOS1LPL
SCHEMBL613331 0.72 TAAR1 (0.48) CYP4F2CYP4A11TBXA2RNOS1CYP1A2
SCHEMBL8464457 0.72 CYP4F2 (0.54) CYP4F2CYP4A11TBXA2RLPLLIPG
SCHEMBL27451458 0.72 ENPP2 (0.52) CYP4F2CYP4A11TBXA2RNOS1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238133-A1 CYCLOPROPANATION METHOD OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238133-A1 CYCLOPROPANATION METHOD ADH1A, ADH1C, ADH5 CYP4F2 179/4885CYP4A11 38/4885MEN1 4557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.